Ron Schaafsma

1.4k total citations
7 papers, 124 citations indexed

About

Ron Schaafsma is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Ron Schaafsma has authored 7 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ron Schaafsma's work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (2 papers) and Acute Myeloid Leukemia Research (1 paper). Ron Schaafsma is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (2 papers) and Acute Myeloid Leukemia Research (1 paper). Ron Schaafsma collaborates with scholars based in Netherlands, Switzerland and Germany. Ron Schaafsma's co-authors include Edo Vellenga, Harry C. Schouten, Jan J. Cornelissen, Mario Bargetzi, Carlos Graux, Johan Maertens, Peter C. Huijgens, Wim van Putten, Matthias Theobald and Gert J. Ossenkoppele and has published in prestigious journals such as Blood, Bone Marrow Transplantation and European Journal of Cancer Care.

In The Last Decade

Ron Schaafsma

6 papers receiving 122 citations

Peers

Ron Schaafsma

HEMAT

PHEOH

MB

ONCOL

GENET

Ashley Morris Engemann United States

Maxi Wass Germany

Dalia Mahmoud United States

Elena Smith United States

Iyas Hamwi Germany

Patricia Disperati Canada

Ibrahim Ghemlas Saudi Arabia

Kyle Beckman United States

Paulina Richter‐Pechańska Germany

M. Trebo Austria

Ashley Morris Engemann United States

Ron Schaafsma

75 ×0.8

HEMAT

8 ×0.2

PHEOH

14 ×0.5

MB

34 ×1.6

ONCOL

10 ×0.8

GENET

Citations per year, relative to Ron Schaafsma Ron Schaafsma (= 1×) peers Ashley Morris Engemann

Countries citing papers authored by Ron Schaafsma

Since Specialization

Citations

This map shows the geographic impact of Ron Schaafsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Schaafsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Schaafsma more than expected).

Fields of papers citing papers by Ron Schaafsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Schaafsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Schaafsma. The network helps show where Ron Schaafsma may publish in the future.

Co-authorship network of co-authors of Ron Schaafsma

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Schaafsma. A scholar is included among the top collaborators of Ron Schaafsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Schaafsma. Ron Schaafsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Schaafsma, Ron, et al.. (2019). Optimising pharmacotherapy in older cancer patients with polypharmacy. European Journal of Cancer Care. 29(1). e13185–e13185. 15 indexed citations

2.

Vellenga, Edo, Wim van Putten, Gert J. Ossenkoppele, et al.. (2011). Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood. 118(23). 6037–6042. 85 indexed citations

3.

Minnema, Monique C., Suzanne van Dorp, Niels W.C.J. van de Donk, et al.. (2010). Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience. Bone Marrow Transplantation. 46(2). 244–249. 6 indexed citations

4.

Dorp, Suzanne van, Niels W.C.J. van de Donk, J.L. Coenen, et al.. (2009). A288 Non-Myeloablative Allo-SCT for Relapsed Myeloma: A Single-Center Experience. Clinical Lymphoma & Myeloma. 9. S48–S48.

5.

Lokhorst, H M, Corien Eeltink, Ron Schaafsma, et al.. (2008). PRETREATMENT WITH THALIDOMIDE AND BORTEZOMIB DOES NOT INFLUENCE RESPONSE TO LENALIDOMIDE IN RELAPSED MYELOMA. PRELIMINARY RESULTS FROM PATIENTS INCLUDED IN DUTCH COMPASSIONATE NEED PROGRAMME. Data Archiving and Networked Services (DANS). 93. 262–262. 1 indexed citations

6.

Sonneveld, Pieter, Bronno van der Holt, Christine M. Segeren, et al.. (2004). Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Updated Analysis of the Randomized Phase III Study HOVON 24 MM.. Blood. 104(11). 948–948. 8 indexed citations

7.

Metselaar, Herold J., Rutger J. Ploeg, Anton M. van Loon, et al.. (1988). Prevention of CMV Infection by Screening for CMV Antibodies in Renal Allograft Recipients and Their Blood and Kidney Donors. Scandinavian Journal of Infectious Diseases. 20(2). 135–139. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact